Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Further re Directorate Change

31 Jan 2018 09:37

RNS Number : 4677D
Cenkos Securities PLC
31 January 2018
 

31 January 2018

 

Cenkos Securities plc

("Cenkos" or the "Company")

 

Further re Directorate Change

 

On 13 September 2017 the Company announced the appointment of Philip Anderson as the Company's Finance Director and as an executive director of the Company, subject to Financial Conduct Authority approval. The Company announces that FCA approval of Philip Anderson's appointment has now been received and that as a result, Mr Anderson's appointment to the board of directors has now become effective.

 

 

Enquiries:

 

Anthony Hotson

Chief Executive Officer

Cenkos Securities plc

 

+44 20 7397 8900

Dr Azhic Basirov / David Jones / Ben Jeynes

Nominated Adviser and Broker

Smith & Williamson Corporate Finance Limited

 

+44 20 7131 4000

David Rydell

Buchanan Communications

 

+44 20 3466 5066

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FURGCGDBUXXBGIB

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.